Human papillomavirus vaccination status among university students in Southern Thailand: A cross-sectional study DOI Creative Commons
Supinya Sono,

Natthapong Sukhanonsawat,

Nuttida Naknuan

et al.

Preventive Medicine Reports, Journal Year: 2024, Volume and Issue: 46, P. 102857 - 102857

Published: Aug. 13, 2024

Human papillomavirus (HPV) commonly causes transmissible diseases worldwide; however, HPV vaccines are not available among some at-risk populations. Since 2017, vaccination has been recommended for females aged 11-12 years in Thailand. However, studies on the coverage and prevalence limited. This study aimed to explore factors associated with Thai university students.

Language: Английский

Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland DOI

Siobhan McCormack,

Claire Thompson,

Miriam Nolan

et al.

Immunity Inflammation and Disease, Journal Year: 2024, Volume and Issue: 12(4)

Published: April 1, 2024

Abstract Background Respiratory syncytial virus (RSV) is the world's leading cause of viral acute lower respiratory infections (ALRI) in infants. WHO has identified maternal RSV vaccination a priority and candidate vaccines are development; however, vaccine hesitancy remains an impediment to successful implementation immunization. This study, largest antenatal survey conducted to‐date, aimed examine awareness, likely acceptance pregnancy, attitudes vaccination. Methods Pregnant women all gestations attending clinic university maternity hospital Ireland were invited participate. An information leaflet provided, consent obtained, administered examining willingness avail vaccination, factors influencing acceptability preferred sources assistance. Research Ethics Committee (REC) approval general data protection regulation (GDPR) guidelines followed. Results 528 completed survey. A large proportion (75.6%) had never heard RSV, yet 48.5% would still vaccine, 45.8% undecided only 5.3% not. The main factor making acceptable (76.4%) was that it protects their infant from illness ( p < .001, CV 0.336 for association with acceptance) practitioner (GP) guidance source decision‐making (57.7%). Conclusions Despite low levels awareness pregnant open availing Maternal immunization strategies need focus on infant's RSV‐associated ALRI along safety, build interdisciplinary collaboration maternal, neonatal, primary care public health services.

Language: Английский

Citations

12

Pregnant women's choices for preventing respiratory syncytial virus (RSV) DOI Creative Commons
Bing Wang, Zohra S Lassi, Prabha H. Andraweera

et al.

Vaccine, Journal Year: 2025, Volume and Issue: unknown, P. 126790 - 126790

Published: Jan. 1, 2025

Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants can lead to severe respiratory distress, especially very young infants. No specific treatments exist for RSV. However, new preventative strategies have become available including RSV vaccine pregnant women monoclonal antibody This study aimed identify understand barriers facilitators uptake a determine their underlying choices maternal immunisation program. Additionally, investigated choice vaccination or administration long-lasting Eligible participants were residing Australia aged 18 years older. Focus group discussions individual online interviews conducted data analysed using thematic analysis approach. A total 34 participated focus interviews, with an average age years. The identified themes categorised into four overarching domains: 1) motivators vaccinating during pregnancy safeguard babies prevent diseases, 2) safety concerns, uncertainties regarding effectiveness, hesitancy arising from COVID-19 experiences, 3) preferred promotion strategies, constant reminders/prompts, personalised messages, campaign focusing on serious outcomes diverse/lay languages, recommendations local obstetricians health authorities, 4) clear recommendation policies preference over infant immunisation. was generally welcomed by our comparing other strategies. Preferences program included diversity "nudge" reminders, healthcare providers.

Language: Английский

Citations

1

Acceptance and preference between respiratory syncytial virus vaccination during pregnancy and infant monoclonal antibody among pregnant and postpartum persons in Canada DOI Creative Commons
Elisabeth McClymont, Jennifer S. Wong,

Lucia Forward

et al.

Vaccine, Journal Year: 2025, Volume and Issue: 50, P. 126818 - 126818

Published: Feb. 6, 2025

Language: Английский

Citations

1

Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review DOI Creative Commons
Teresa Gavaruzzi, Andrea Ceccarelli, Cristina Nanni

et al.

Vaccines, Journal Year: 2025, Volume and Issue: 13(2), P. 159 - 159

Published: Feb. 6, 2025

Background: New strategies for respiratory syncytial virus (RSV) prevention are available and in development, but their acceptance is crucial to effectiveness. Objectives: This systematic review aims summarize current quantitative qualitative evidence regarding knowledge attitudes relating RSV prevention. Methods: Six databases (PubMed, Scopus, APA PsycArticles; PsycInfo; CINAHL Complete; Psychology Behavioral Sciences Collection) two preprint repositories (medRxiv Preprints) were searched up until 23 December 2024 (PROSPERO: CRD42024602351). Results: Sixty-one articles included, focusing on vaccination the elderly adults at risk (n = 10) or pregnant people 24, of which 8 also examined preferences maternal vs. infant immunization) immunization 27, 16 focused palivizumab, with 6 adherence its monthly administration). Eighteen assessed healthcare professionals. Overall, findings showed limited awareness generally positive towards moderate high intentions uptake rates. Protection against disease perceived severity promoted acceptance, whereas concerns about side effects hindered it. Maternal was more acceptable than immunization. Conclusions: Attitudes options favorable. Should become available, may depend characteristics, how they framed presented. These insights highlight importance education grounded decision-making literature, while recognizing likely favorable reception preventive measures across target age-populations.

Language: Английский

Citations

1

Respiratory Syncytial Vaccination: Parents’ Willingness to Vaccinate Their Children DOI Creative Commons
Vincenza Sansone, Silvia Angelillo, Francesca Licata

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(4), P. 418 - 418

Published: April 15, 2024

Background: This study was conducted to assess parents’ willingness vaccinate their children with the RSV vaccine and key predictors of this intention among parents in Italy. Methods: Data were collected using an anonymous self-administered questionnaire from April November 2023, targeting public kindergartens nursery schools southern The survey assessed socio-demographic characteristics, health-related details, child’s health status, attitudes toward infection its vaccine, source(s) information. Results: A total 404 agreed participate study. Only 18.2% participants very concerned that could get infected by RSV, concern more likely whose child had been diagnosed bronchiolitis, those who received information HCWs, heard needed additional Almost half (51.3%) willing child, inclination fathers, employed parents, daughters, Conclusions: An educational campaign regarding a future especially about safety efficacy, is order improve willingness.

Language: Английский

Citations

5

Factors influencing acceptance of RSV immunization for newborns among pregnant individuals: A mixed-methods study DOI Creative Commons
Dominique Gagnon,

Charlotte Gubany,

Manale Ouakki

et al.

Vaccine, Journal Year: 2025, Volume and Issue: 55, P. 127062 - 127062

Published: March 31, 2025

Respiratory syncytial virus (RSV) is a major cause of respiratory infections and hospitalizations in Canadian infants. Recently, Health Canada approved two novel immunizing products: vaccine given during pregnancy monoclonal antibody for This study assessed knowledge, attitudes, intentions regarding RSV its prevention among pregnant individuals. A mixed-methods was conducted Quebec from October to December 2023. Pregnant individuals were recruited through targeted Facebook advertisements. Data collected phases: Phase 1 involved an online survey assess knowledge RSV, attitudes toward immunization, both immunization products, followed by qualitative interviews 2 explore factors impacting decision-making preferences prevention. Survey data analyzed using descriptive statistics; interview thematic analysis. Among participants (n = 803), 68.4 % reported some RSV. Intention products high, with 88.1 willing receive the 92 %, administer antibodies their majority (69 %) preferred vaccination over antibodies. The desire protect infant severe complications key motivating factor acceptance new products. Other determinants included safety, efficacy, recommendations healthcare providers. Qualitative 25) highlighted safety concerns expectant parents about these importance clear evidence-based providers also emphasized. demonstrated high level interest infants, whether or Recommendations availability information on efficacy will be move intention action.

Language: Английский

Citations

0

Knowledge, willingness, and hesitancy toward recommended vaccinations among pregnant and post-partum women: A cross-sectional survey in Italy DOI Creative Commons
Grazia Miraglia del Giudice, Silvia Angelillo, Vincenza Sansone

et al.

Human Vaccines & Immunotherapeutics, Journal Year: 2025, Volume and Issue: 21(1)

Published: April 17, 2025

The objectives of the cross-sectional survey were to examine knowledge, attitudes, and hesitancy among pregnant post-partum women toward recommended vaccinations identify determinants. was conducted from July September 2024 in Naples, Italy. Out a total 585 participants, 64.1% had been infected with at least one MMRV diseases 47.3% received vaccinations. Only 21.4% knew that post-partum, this more frequent healthcare workers (HCWs) or those who partner working sector no history infections. overall mean Vaccine Hesitancy Scale (VHS) score 24.1 43.6% high-hesitant (score ≥ 25). Participants higher level education, non-Italian nationality, infections pregnancy-related health problems, aware complications during pregnancy, perception knowledge about acquired information HCWs, needed further odds low regarding as measured by VHS instrument. More than one-third expressed willingness receive post-partum. Respondents information, not high vaccine hesitant willing findings revealed an inadequate significant prevalence public efforts, informative campaigns utility are needed.

Language: Английский

Citations

0

Prospective Attitudes Towards Respiratory Syncytial Virus (RSV) Vaccine in Pregnant Women in Greece DOI

Anna Damatopoulou,

Michail Matalliotakis,

Ypatia Diamanta

et al.

Behavioral Medicine, Journal Year: 2024, Volume and Issue: 51(1), P. 1 - 6

Published: Nov. 15, 2024

Respiratory Syncytial Virus (RSV) is a common respiratory pathogen with high morbidity and mortality, especially in children under two years of age. Severe RSV infection poses significant threat to healthcare systems, making vaccination an utmost need. In August 2023, the U.S. FDA approved maternal vaccine prevent lower tract disease (LRTD) infants throughout their first six months life. This cross-sectional survey was designed evaluate pregnant women's willingness receive during pregnancy. An anonymous administered from April 2023 December women aged above 16 old attending gynecology wards randomly selected public private hospitals Crete. The primary outcome intention vaccine. Univariable multivariable analyses were carried out identify factors associated get vaccinated. Questionnaires distributed sample 335 females who agreed participate this study. vaccinated against positively educational level, presence school-age children, awareness, routine pregnancy vaccines according National Immunization Program (NIP), previous COVID-19. majority not familiar term upcoming campaign regarding its required improve perceptions support workers promoting it upon availability Greece.

Language: Английский

Citations

3

Investigating parental perceptions of respiratory syncytial virus (RSV) and attitudes to RSV vaccine in Jiangsu, China: Insights from a cross-section study DOI Creative Commons
Qiang Wang, Liuqing Yang, Lan Li

et al.

Vaccine, Journal Year: 2024, Volume and Issue: 44, P. 126570 - 126570

Published: Nov. 29, 2024

Language: Английский

Citations

2

Opportunities and challenges to the development and deployment of vaccines for pregnant women in Germany DOI Creative Commons
Caitlin Pley, Beate Kampmann

Vaccine, Journal Year: 2024, Volume and Issue: 42(20), P. 126094 - 126094

Published: June 29, 2024

Maternal immunisation is a powerful tool to protect both pregnant women and their children. A new maternal RSV vaccine holds promise newborns from RSV-associated illness in the first few months of life, but no official recommendation has been made Germany. Since causes significant burden paediatric hospital admissions, we consider it pertinent opportunity review barriers vaccination Germany, which might also apply other settings. Access for Germany shaped by an interplay legal, regulatory, institutional, sociocultural factors, with less permissive clinical research environment, delays roll-out, lower acceptance healthcare professionals population. Actionable recommendations improve availability uptake include coordination national regulatory bodies reduce delays, awareness literacy campaigns health general public, capacity building research.

Language: Английский

Citations

1